
The rapid advancement of digital healthcare technology (DHT) and AI has offered great opportunities for an R&D organization to upscale in both what and how we deliver innovative life-saving therapeutics for patients in need and how we transform daily workflows to work smarter and faster.
If you have a strong background in clinical research and development and are passionate about development of novel DHT for patient screening, symptom and event early capture, digital biomarker and endpoint, as well as how to incorporate AI into the daily workflow, we encourage you to explore this unique opportunity.
In this role, you will be responsible to lead and drive the internal and external collaborations to deliver and to accelerate development of 0-to-1 novel DHT based solutions. In addition, leverage your rich clinical development know-how and experience, you will also serve as subject SME and function as a key member of multidisciplinary fusion team, working closely with AI engineers and technology partners, to develop quality and fit-for-purpose Agentic solutions that can make daily work smarter and faster.
Major responsibilities
Education, Qualifications, Skills and Experience
Date Posted
26-2月-2026
Closing Date
29-9月-2026
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.

We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com.
Community Guidelines: bit.ly/2MgAcio